We performed qRT-PCR analysis and Western blotting to test FoxM1 and MYBL2 expression in high-grade glioma cell lines (U251, U87, U343 and T98G), low-grade cell line (Hs683) and 9 normal tissues. This evidence concerns the gene FOXM1 and glioma.